Browse Drug Recalls
14,380 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 14,380 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 14,380 FDA drug recalls, Class II.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Nov 27, 2018 | Amlodipine and Valsartan Tablets 5 mg/320 mg, (a) 30-count bottles (NDC 0093-... | CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine... | Class II | Teva Pharmaceuticals USA |
| Nov 27, 2018 | Amlodipine and Valsartan Tablets 10 mg/320 mg (a) 30-count bottles (NDC 0093... | CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine... | Class II | Teva Pharmaceuticals USA |
| Nov 27, 2018 | Amlodipine, Valsartan, and Hydrochlorothiazide Tablets 10 mg/320 mg/25 mg, (... | CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine... | Class II | Teva Pharmaceuticals USA |
| Nov 27, 2018 | Amlodipine and Valsartan Tablets 10 mg/160 mg, (a) 30-count bottles (NDC 0093... | CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine... | Class II | Teva Pharmaceuticals USA |
| Nov 27, 2018 | Amlodipine, Valsartan, and Hydrochlorothiazide Tablets 10 mg/160 mg/12.5 mg, ... | CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine... | Class II | Teva Pharmaceuticals USA |
| Nov 27, 2018 | Amlodipine, Valsartan, and Hydrochlorothiazide Tablets 10 mg/160 mg/25 mg, (... | CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine... | Class II | Teva Pharmaceuticals USA |
| Nov 27, 2018 | Amlodipine, Valsartan, and Hydrochlorothiazide Tablets 5 mg/160 mg/12.5 mg, ... | CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine... | Class II | Teva Pharmaceuticals USA |
| Nov 26, 2018 | infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 m... | Superpotent Drug: recalled lots may have higher concentration of ibuprofen. | Class II | Tris Pharma Inc. |
| Nov 26, 2018 | Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 ... | Superpotent Drug: recalled lots may have higher concentration of ibuprofen. | Class II | Tris Pharma Inc. |
| Nov 26, 2018 | Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 ... | Superpotent Drug: recalled lots may have higher concentration of ibuprofen. | Class II | Tris Pharma Inc. |
| Nov 20, 2018 | Germ Bloc Health Hand Sanitizer Foam (benzalkonium chloride 0.13%) 7.5fl.oz./... | Microbial Contamination of Non-Sterile Product: Presence of Pseudomonas aeruginosa in product | Class II | AVKARE Inc. |
| Nov 20, 2018 | Amlodipine and Valsartan Tablets, USP,10 mg/160 mg, 30-count bottle, Rx Only,... | CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained i... | Class II | Mylan Pharmaceuticals Inc. |
| Nov 20, 2018 | Amlodipine and Valsartan Tablets, USP, 10 mg/320 mg, 30-count bottle, Rx Only... | CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained i... | Class II | Mylan Pharmaceuticals Inc. |
| Nov 20, 2018 | Amlodipine and Valsartan Tablets, USP, 5 mg/160 mg, 30-count bottle, Rx Only,... | CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained i... | Class II | Mylan Pharmaceuticals Inc. |
| Nov 20, 2018 | Valsartan Tablets, USP, 320 mg, 90-count bottle, Rx Only, Made in India, Manu... | CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained i... | Class II | Mylan Pharmaceuticals Inc. |
| Nov 20, 2018 | Valsartan Tablets, USP, 40 mg, 30-count bottle, Rx Only, Made in India, Manuf... | CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained i... | Class II | Mylan Pharmaceuticals Inc. |
| Nov 20, 2018 | Valsartan Tablets, USP, 160 mg, 90-count bottle, Rx Only, Made in India, Manu... | CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained i... | Class II | Mylan Pharmaceuticals Inc. |
| Nov 20, 2018 | Valsartan and Hydrochlorothiazide Tablets, USP, 320 mg/25 mg, (a) 500-count b... | CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained i... | Class II | Mylan Pharmaceuticals Inc. |
| Nov 20, 2018 | Valsartan Tablets, USP, 80 mg, 90-count bottles, Rx Only, Made in India, Manu... | CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained i... | Class II | Mylan Pharmaceuticals Inc. |
| Nov 19, 2018 | Human Chorionic Gonadotropin 3000 IU, Rx only, Pharm D. Solutions 1304 South ... | Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of pro... | Class II | Pharm D Solutions, LLC |
| Nov 16, 2018 | SHEER DesenZ Desensitizing Treatment, Rx Only, Potassium Nitrate 12mg per fil... | cGMP violations noted during the firm's most recent inspection. | Class II | CAO Group, Inc. |
| Nov 16, 2018 | fas.TRACT Coagulative Hemostatic Gel, 10% Ferric Sulfate Kit, Rx Only, (3) 3c... | cGMP violations noted during the firm's most recent inspection. | Class II | CAO Group, Inc. |
| Nov 16, 2018 | FastStat Topical Hemostat Introductory Kit, 10% Ferric Sulfate 10%, Rx Only, ... | cGMP violations noted during the firm's most recent inspection. | Class II | CAO Group, Inc. |
| Nov 16, 2018 | BeeGentle Honey Flavored Topical Anesthetic, Active ingredient Benzocaine 20%... | cGMP violations noted during the firm's most recent inspection. | Class II | CAO Group, Inc. |
| Nov 14, 2018 | Quetiapine Tablets USP 400 mg, 100 tablet bottles, Rx Only, Manufactured by:... | Presence of Foreign Substance; metal shard found in tablet | Class II | Ascend Laboratories LLC |
| Nov 9, 2018 | Equi-Soft Foam, Antimicrobial Hand Soap, 0.55% Benzalkonium Chloride, 25 fl o... | Labeling: Label mix-up - the label on the product may not match the formula in the bottle. | Class II | Ecolab Inc |
| Nov 9, 2018 | Medi-Stat Foam, Antimicrobial Hand Soap, Chloroxylenol 0.5%, 1250 mL (42.3 fl... | Labeling: Label mix-up - the label on the product may not match the formula in the bottle. | Class II | Ecolab Inc |
| Nov 8, 2018 | INFed (Iron Dextran Injection USP) 100 mg elemental iron/2 mL (50 mg/mL), Rx ... | Failed Stability Specification: out of specification for iron content. | Class II | ALLERGAN |
| Nov 7, 2018 | Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx... | Failed Dissolution Specification: Out-of-Specification results were observed for dissolution at 1... | Class II | Dr. Reddy's Laboratories, Inc. |
| Nov 6, 2018 | Antacid Tablets, Calcium Carbonate chewable tablets, 750mg, 60-count bottle, ... | Presence of foreign substance: Product found to contain metal particles. | Class II | L. Perrigo Company |
| Nov 2, 2018 | Curaplex Epi Kit NOT FOR IV USE, #8600-01120, Epi-Safe Kit 8600-01 120 contai... | Labeling Incorrect Instructions: This recall has been initiated because the Instructions for Use... | Class II | Bound Tree Medical, LLC |
| Nov 2, 2018 | Curaplex Epi Safe Kit, 8600-01102 TRAINING ONLY, Rx Only, Distributed by Sarn... | Labeling Incorrect Instructions: This recall has been initiated because the Instructions for Use... | Class II | Bound Tree Medical, LLC |
| Nov 2, 2018 | curaplex Epi Safe Administration and Training Kits, #8600-01100, Contains: 2 ... | Labeling Incorrect Instructions: This recall has been initiated because the Instructions for Use... | Class II | Bound Tree Medical, LLC |
| Nov 2, 2018 | IRBESARTAN Tablets, USP 300 mg (a) 30-count bottle (NDC 60429-642-30), (b) 90... | CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine ... | Class II | Golden State Medical Supply Inc. |
| Nov 2, 2018 | curaplex Epi Safe Kit, 8600-01101, contains:" 1ml Vial of Epinephrine " 1 Ep... | Labeling Incorrect Instructions: This recall has been initiated because the Instructions for Use... | Class II | Bound Tree Medical, LLC |
| Nov 2, 2018 | Isosorbide Dinitrate Tablets, USP 20 mg,100-count bottles, Rx Only Manufactur... | Cross Contamination with Other Products | Class II | Sandoz Inc |
| Nov 2, 2018 | Isosorbide Dinitrate Tablets, USP 10 mg,100-count bottles, Rx Only Manufactur... | Cross Contamination with Other Products | Class II | Sandoz Inc |
| Nov 2, 2018 | IRBESARTAN Tablets, USP 150 mg (a) 30-count bottle (NDC 60429-641-30), (b) 90... | CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine ... | Class II | Golden State Medical Supply Inc. |
| Nov 2, 2018 | IRBESARTAN Tablets, USP 75 mg 90-count bottle, Rx Only, Manufactured by: SciG... | CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine ... | Class II | Golden State Medical Supply Inc. |
| Nov 2, 2018 | Isosorbide Dinitrate Tablets, USP 20 mg, 100-count bottles, Rx Only, Distribu... | Cross Contamination with Other Products | Class II | Sandoz Inc |
| Nov 2, 2018 | Isosorbide Dinitrate Tablets, USP 5 mg,100-count bottles, Rx Only Manufacture... | Cross Contamination with Other Products | Class II | Sandoz Inc |
| Nov 1, 2018 | curaplex Epi Safe Administration and Training Kits # 8600-01100. Kit contains... | Labeling: Incorrect or Missing Lot and/or Exp date: vials of epinephrine within kit 8600-01100 e... | Class II | Bound Tree Medical, LLC |
| Nov 1, 2018 | Sandoz Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg, ... | CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained i... | Class II | Sandoz, Inc |
| Oct 31, 2018 | BEVACIZUMAB 2.5 MG/0.1ML, pre-filled syringe (deliverable dose of 1.25MG in n... | Lack of Assurance of Sterility | Class II | Avella of Deer Valley, Inc. Store 38 |
| Oct 29, 2018 | Westminister Irbesartan Tablets, USP, 75 mg (a) 30-count bottle (NDC 69367-11... | CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine... | Class II | Sciegen Pharmaceuticals Inc |
| Oct 29, 2018 | Omnipaque (iohexol) Injection, 180mgI/mL, 20 mL Single-Dose Vial, packaged in... | Defective Container: vial defect was identified that could potentially impact the container closu... | Class II | GE Healthcare Inc. Life Sciences |
| Oct 29, 2018 | GSMS Irbesartan Tablets, USP, 150 mg, (a) 30-count bottle (NDC 60429-641-30),... | CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine... | Class II | Sciegen Pharmaceuticals Inc |
| Oct 29, 2018 | Westminister Irbesartan Tablets, USP, 150 mg, (a) 30-count bottle (NDC 69367-... | CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine... | Class II | Sciegen Pharmaceuticals Inc |
| Oct 29, 2018 | GSMS Irbesartan Tablets, USP, 75 mg, 30-count bottle, Rx Only, Manufactured b... | CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine... | Class II | Sciegen Pharmaceuticals Inc |
| Oct 29, 2018 | Westminster Irbesartan Tablets, USP 75 mg Rx Only Manufactured by: ScieGen Ph... | CGMP Deviations: FDA laboratory testing confirmed traces of NDEA impurity in specific lots of Ir... | Class II | Westminster Pharmaceuticals Llc |
Frequently Asked Questions
When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.